相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical proteomics in neurodegenerative disorders
H. Zetterberg et al.
ACTA NEUROLOGICA SCANDINAVICA (2008)
Advances in the genetics of Parkinson's disease
Serena Rosner et al.
ACTA PHARMACOLOGICA SINICA (2008)
CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases
Jing Zhang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Serum urate as a predictor of clinical and radiographic progression in Parkinson disease
Michael A. Schwarzschild et al.
ARCHIVES OF NEUROLOGY (2008)
Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
Brit Mollenhauer et al.
EXPERIMENTAL NEUROLOGY (2008)
Blood-based proteomics for personalized medicine: examples from neurodegenerative disease
Ira L. Goldknopf
EXPERT REVIEW OF PROTEOMICS (2008)
Developing new treatments for Alzheimer's disease: the who, what, when, and how of biomarker-guided therapies
Constantine G. Lyketsos et al.
INTERNATIONAL PSYCHOGERIATRICS (2008)
REM sleep behaviour disorder in Parkinson's disease is associated with specific motor features
R. B. Postuma et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Biomarkers for the early detection of Parkinson's and Alzheimer's disease
Daniela Berg
NEURODEGENERATIVE DISEASES (2008)
Biochemical markers in persons with preclinical familial Alzheimer disease
J. M. Ringman et al.
NEUROLOGY (2008)
Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: Differentiation, early detection, and implications for mild cognitive impairment and biomarkers
Alexander I. Troster
NEUROPSYCHOLOGY REVIEW (2008)
Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases
Markus Otto et al.
METHODS (2008)
Secretion of DJ-1 into the serum of patients with Parkinson's disease
Chinatsu Maita et al.
NEUROSCIENCE LETTERS (2008)
GATA transcription factors directly regulate the Parkinson's disease-linked gene α-synuclein
Clemens R. Scherzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Technology Insight: imaging neuro degeneration in Parkinson's disease
David J. Brooks
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
Biomarkers for early detection of Alzheimer pathology
C. M. Clark et al.
NEUROSIGNALS (2008)
REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia
M. Vendette et al.
NEUROLOGY (2007)
Sniffing out Parkinson disease - Can olfactory testing differentiate parkinsonian disorders?
Jonathan H. McKinnon et al.
NEUROLOGIST (2007)
Skin biopsy: a new diagnostic tool for autonomic dysfunctions in Parkinson's disease?
Aroldo Rossi et al.
LANCET NEUROLOGY (2007)
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease
Norman L. Foster et al.
BRAIN (2007)
Assessment of the progression of Parkinson's disease: a metabolic network approach
Thomas Eckert et al.
LANCET NEUROLOGY (2007)
Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson's disease
Masaaki Waragai et al.
NEUROSCIENCE LETTERS (2007)
Plasma urate and risk of Parkinson's disease
M. G. Weisskopf et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Skin biopsy in the management of peripheral neuropathy
Claudia Sommer et al.
LANCET NEUROLOGY (2007)
Molecular markers of early Parkinson's disease based on gene expression in blood
Clemens R. Scherzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Applying transcriptomic and proteomic knowledge to Parkinson's disease drug discovery
Silvia Mandel et al.
EXPERT OPINION ON DRUG DISCOVERY (2007)
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
Henry Engler et al.
BRAIN (2006)
Biomarkers in the diagnosis of Alzheimer's disease: Are we ready?
Trey Sunderland et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2006)
Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease
Masaaki Waragai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Amyloid load and cerebral atrophy in Alzheimer's disease:: An 11C-PIB positron emission tomography study
Hilary A. Archer et al.
ANNALS OF NEUROLOGY (2006)
Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease
IL Goldknopf et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Evaluating the comparability of gene expression in blood and brain
PF Sullivan et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2006)
Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease
Omar M. A. El-Agnaf et al.
FASEB JOURNAL (2006)
Transcriptional profiling of peripheral blood cells in clinical pharmacogenomic studies
ME Burczynski et al.
PHARMACOGENOMICS (2006)
2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseases
Essam A. Sheta et al.
EXPERT REVIEW OF PROTEOMICS (2006)
Prostaglandin D synthase isoforms from cerebrospinal fluid vary with brain pathology
Michael G. Harrington et al.
DISEASE MARKERS (2006)
Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia
SJ Glatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system
P Remy et al.
BRAIN (2005)
In vivo measurement of T1ρ dispersion in the human brain at 1.5 tesla
A Borthakur et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2004)
Iron, brain ageing and neurodegenerative disorders
L Zecca et al.
NATURE REVIEWS NEUROSCIENCE (2004)
The current status of Alzheimer's disease genetics: what do we tell the patients?
L Bertram et al.
PHARMACOLOGICAL RESEARCH (2004)
Cerebrospinal fluid tau and β-amyloid -: How well do these biomarkers reflect autopsy-confirmed dementia diagnoses?
CM Clark et al.
ARCHIVES OF NEUROLOGY (2003)
Cerebrospinal fluid tau levels in Alzheimer's disease are elevated when compared with vascular dementia but do not correlate with measures of cerebral atrophy
P Schönknecht et al.
PSYCHIATRY RESEARCH (2003)
Evidence for deficiencies in perceptual and semantic olfactory processes in Parkinson's disease
J Hudry et al.
CHEMICAL SENSES (2003)
Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging
G Chetelat et al.
NEUROIMAGE (2003)
The differential diagnosis of Parkinson's disease
W Poewe et al.
EUROPEAN JOURNAL OF NEUROLOGY (2002)
Prevalence of mild cognitive impairment:: a population-based study in elderly subjects
T Hänninen et al.
ACTA NEUROLOGICA SCANDINAVICA (2002)
Oxidative damage and cytogenetic analysis in leukocytes of Parkinson's disease patients
L Migliore et al.
NEUROLOGY (2002)
Echogenicity of the substantia nigra -: Association with increased iron content and marker for susceptibility to nigrostriatal injury
D Berg et al.
ARCHIVES OF NEUROLOGY (2002)
Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson's disease
DJ Burn
MOVEMENT DISORDERS (2002)
Differential rates of regional brain change in callosal and ventricular size: a 4-year longitudinal MRI study of elderly men
EV Sullivan et al.
CEREBRAL CORTEX (2002)
Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD
N Schuff et al.
NEUROLOGY (2002)
Positron emission tomography in evaluation of dementia - Regional brain metabolism and long-term outcome
DHS Silverman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
CSF total tau, aβ42 and phosphorylated tau protein as biomarkers for Alzheimer's disease
K Blennow et al.
MOLECULAR NEUROBIOLOGY (2001)
Echogenicity of the substantia nigra in Parkinsons disease and its relation to clinical findings
D Berg et al.
JOURNAL OF NEUROLOGY (2001)
SPECT perfusion imaging in the diagnosis of Alzheimer's disease - A clinical-pathologic study
W Jagust et al.
NEUROLOGY (2001)
Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice
N Andreasen et al.
ARCHIVES OF NEUROLOGY (2001)
Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's disease
B Caronti et al.
JOURNAL OF NEURAL TRANSMISSION (2001)
Pathophysiology of the basal ganglia in Parkinson's disease
JA Obeso et al.
TRENDS IN NEUROSCIENCES (2000)
Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD
F Jessen et al.
NEUROLOGY (2000)
Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease -: A 1H MRS study
K Kantarci et al.
NEUROLOGY (2000)
Age-specific incidence rates of Alzheimer's disease - The Baltimore Longitudinal Study of Aging
C Kawas et al.
NEUROLOGY (2000)
One-year age changes in MRI brain volumes in older adults
SM Resnick et al.
CEREBRAL CORTEX (2000)
Genetic and biochemical markers for Alzheimer's disease: recent developments
C Mulder et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2000)
分享论文
